Eagle Rock Investment Company’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
ECSS
ATO
Eagle Rock Investment Company's ABBV Position: Q2 2026 in Review
Eagle Rock Investment Company held its AbbVie (ABBV) position steady in Q2 2026 at 5,335 shares worth $1.34M. The position accounts for 0.17% of the portfolio, ranked #84.
Eagle Rock Investment Company first reported a position in ABBV in Q4 2021 and has held it in 19 quarters since. The position peaked at $5.35M in Q4 2021. 1,882 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Eagle Rock Investment Company held 5,335 shares of AbbVie worth $1.34M as of Q2 2026.
- Eagle Rock Investment Company left its AbbVie share count unchanged in Q2 2026.
- AbbVie made up 0.17% of Eagle Rock Investment Company's portfolio in Q2 2026, its #84 holding.
- Eagle Rock Investment Company first reported a position in AbbVie in Q4 2021 and has held it in 19 quarters since.
- Eagle Rock Investment Company's AbbVie position peaked at $5.35M in Q4 2021.
- 1,882 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Eagle Rock Investment Company's 13F filing for Q2 2026, filed 9 Jul 2026.